|
Volumn 11, Issue 2, 2001, Pages 175-182
|
Preclinical targeted alpha therapy for subcutaneous melanoma
a a a |
Author keywords
In vivo; Local therapy; Melanoma; Systemic therapy; Targeted alpha therapy
|
Indexed keywords
BISMUTH 213;
MONOCLONAL ANTIBODY;
ALPHA RADIATION;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CANCER CELL;
CANCER INHIBITION;
CANCER RADIOTHERAPY;
CARCINOGENESIS;
CONTROLLED STUDY;
MELANOMA;
MOUSE;
NONHUMAN;
PREGANGLIONIC NERVE CELL;
PRIORITY JOURNAL;
SUBCUTANEOUS TISSUE TUMOR;
TUMOR REGRESSION;
ANIMALS;
BISMUTH;
BODY WEIGHT;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOSE-RESPONSE RELATIONSHIP, RADIATION;
HUMANS;
MELANOMA;
MICE;
MICE, INBRED BALB C;
MICE, NUDE;
NEOPLASM TRANSPLANTATION;
RADIOISOTOPES;
SKIN NEOPLASMS;
TIME FACTORS;
TISSUE DISTRIBUTION;
|
EID: 0035028492
PISSN: 09608931
EISSN: None
Source Type: Journal
DOI: 10.1097/00008390-200104000-00013 Document Type: Article |
Times cited : (27)
|
References (10)
|